ADMA
ADMA Biologics Inc
9.50$
+4.3%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +21.3% | +48.5% | +113.5% | -25.4% | +72.8% | +43.9% | +91.7% | +90.4% | +67.6% | +65.2% | +19.6% | |
| – | +15.2% | +47.5% | +358.5% | +44.7% | -6.4% | +55.2% | +30.1% | +48.9% | +42.5% | +22.2% | +5.1% | |
| – | +31.9% | +50.0% | -248.9% | – | – | – | – | +2,906.4% | +152.2% | +146.8% | +33.3% | |
| – | -26.3% | +9.6% | -19.0% | -37.0% | -40.3% | +152.0% | -38.3% | -0.9% | -8.7% | -45.1% | +162.7% | |
| – | +39.8% | +25.9% | +113.0% | +24.4% | +15.1% | +35.3% | +57.4% | +27.4% | -18.4% | +29.2% | +23.5% | |
| – | +1.0% | +17.7% | +48.2% | +9.4% | -10.9% | +46.6% | +29.9% | +25.3% | -9.8% | +19.7% | +25.8% | |
| – | – | – | – | – | – | – | – | – | – | +542.5% | +37.7% | |
| – | +43.3% | +21.5% | +46.7% | +68.1% | +62.8% | +33.3% | +8.9% | +47.7% | +29.8% | -44.3% | -49.0% | |
| – | – | – | – | – | – | – | – | – | – | – | +45.3% | |
| – | – | -11.0% | +103.6% | +22.6% | +60.7% | +35.3% | +8.0% | +50.6% | -57.7% | -981.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | -25.7% | |
| – | – | – | – | – | – | – | – | – | – | +2,784.6% | +34.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.